Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against BioAge Labs, Inc. due to a class action complaint related to the company's IPO and alleged breaches of fiduciary duties by its board of directors [1] Group 1: Legal Investigation - A class action complaint was filed against BioAge on January 7, 2024, concerning its registration statement for the IPO held on September 26, 2024 [1] - The investigation focuses on whether BioAge's board of directors has breached their fiduciary duties to the company [1] Group 2: Product and Market Impact - On December 6, 2024, BioAge announced the discontinuation of the STRIDES Phase 2 trial for its lead product candidate, azelaprag, due to safety concerns related to elevated liver transaminase levels [2] - This announcement was unexpected, as BioAge had previously highlighted azelaprag's potential in patients undergoing obesity therapy with incretin drugs during its IPO [2] Group 3: Stock Price Reaction - Following the announcement regarding the discontinuation of the trial, BioAge's stock price fell significantly from $20.09 per share on December 6, 2024, to $4.65 per share on December 7, 2024 [3]

Core Viewpoint - Johnson Fistel, PLLP has initiated an investigation into CareDx, Inc. for potential breaches of fiduciary duties and violations of federal securities laws [1][2]. Investigation Details - The investigation focuses on actions taken by CareDx insiders between April 30, 2020, and February 24, 2022, which involved issuing false and misleading statements about the company's compliance with healthcare laws and revenue growth [2]. - CareDx began disclosing issues on October 28, 2021, revealing that the company was under multiple government investigations and that its financial results were significantly lower than previously reported [2]. - By November 3, 2022, CareDx's share price had decreased by over 77.22% from its previous levels [2]. Shareholder Information - Current stockholders who have held CareDx stock since at least January 2021 are encouraged to contact Johnson Fistel to discuss their legal rights regarding the investigation [3].

TORONTO, May 20, 2025 (GLOBE NEWSWIRE) -- Mattr Corp. (“Mattr” or the “Company”) (TSX: MATR) announced today in accordance with Toronto Stock Exchange requirements, the voting results from its Annual Meeting held May 15, 2025 in Toronto, Ontario. A total of 43,559,302 common shares were voted at the meeting representing 69.87% of the votes attached to all outstanding shares. Shareholders voted in favour of all items of business before the meeting, including the election of all director nominees as follows: ...

SAN DIEGO, May 20, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of West Pharmaceutical Services, Inc. (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, inclusive (the “Class Period”), have until Monday, July 7, 2025 to seek appointment as lead plaintiff of the West Pharmaceutical class action lawsuit. Captioned New England Teamsters Pension Fund v. West Pharmaceutical Services, Inc., No. 25-cv-02285 (E.D. Pa.), the West Pharmaceutic ...

Core Viewpoint - The Board of Directors of Victoria's Secret & Co. has adopted a limited-duration shareholder rights plan to protect the interests of all shareholders in response to significant stock accumulation by BBRC International Pte Limited [2][3][4] Group 1: Rights Plan Details - The Rights Plan is effective immediately and will expire in one year, specifically on May 18, 2026 [2][8] - Each shareholder will receive one right for each share of common stock as of May 29, 2025, which will initially trade with the common stock [5][8] - The rights become exercisable if any person acquires 15% or more of the outstanding common stock, or 20% for certain passive investors [5][6] Group 2: Rationale for the Rights Plan - The Board adopted the Rights Plan due to the substantial accumulation of shares by BBRC, which began increasing its position to approximately 13% starting in March 2025 [3][6] - The Board expressed concerns about the current market dislocation in the retail sector and its impact on the trading value of the Company's shares, which they believe does not reflect the inherent value of VS&Co [3][4] - The Rights Plan aims to ensure fair treatment of all shareholders in the event of a takeover and to prevent control from being gained without appropriate compensation [4][6] Group 3: Engagement with BBRC - The Company has maintained open dialogue with BBRC and values their investment, indicating a willingness to continue discussions [4] - BBRC has a history of acquiring controlling interests in retail companies and has recently launched a new global lingerie and beauty brand [6][4] Group 4: Company Overview - Victoria's Secret & Co. is a specialty retailer known for its fashion-inspired collections, including lingerie, sleepwear, and beauty products, with a global presence of approximately 1,380 retail stores in nearly 70 countries [9]

Group 1 - A class action has been filed against Krispy Kreme, Inc. for allegedly misleading investors regarding its partnership with McDonald's [1] - The complaint claims that demand for Krispy Kreme products at McDonald's locations declined significantly after the initial marketing launch, impacting average sales [1] - Krispy Kreme reported a net revenue of $375.2 million for Q1 2025, a decline of 15.3%, and a net loss of $33.4 million compared to a net loss of $6.7 million in the prior year [2] Group 2 - The company announced it is reassessing its deployment schedule with McDonald's and has withdrawn its prior full-year outlook due to uncertainty around the partnership [2] - Following the financial results announcement, Krispy Kreme's share price fell by nearly 25%, negatively affecting investors [2] - Shareholders interested in participating in the class action must file their papers by July 15, 2025, to serve as lead plaintiff [3]

ATLANTA, May 19, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Krispy Kreme, Inc. (“Krispy Kreme” or the “Company”) (NASDAQ: DNUT). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse information about Krispy Kreme’s business, operations, and prospects, including allegations that: (1) demand for Krispy Kreme products declined materially at McDonald’s locations after the initial marketing launch ...

Copa Holdings (CPA) is bolstered by its fleet modernization and robust operational efficiency, boosting the company’s prospects. The shareholder-friendly initiative is also commendable. Due to these tailwinds, CPA shares have performed impressively on the bourse. If you have not taken advantage of its share price appreciation yet, it’s time to do so.Let’s delve deeper.Upsides for CPACPA’s Northward Earnings Estimate Revision: The Zacks Consensus Estimate for earnings per share has been revised upward by 1.9 ...

TEJON RANCH, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Tejon Ranch Co. (NYSE:TRC), (“Tejon” or the “Company”), a diversified real estate development and agribusiness company, today announced that, based on the final vote count certified by the independent election inspector following the Company’s 2025 Annual Meeting of Shareholders, Tejon shareholders have voted to re-elect Steven Betts, Gregory Bielli, Denise Gammon, Anthony Leggio, Jeffrey McCall, Norman Metcalfe, Eric Speron, Daniel Tisch and Kenneth Yee ...

Company Overview - Couchbase provides a cloud database platform designed for modern applications, including Couchbase Capella, Couchbase Server, and Couchbase Mobile, focusing on high performance and scalability for mission-critical applications [1] - Couchbase Capella is a fully managed database-as-a-service, while Couchbase Server is a multi-service NoSQL database with SQL-compatible query language SQL++ [1] - Couchbase Mobile is an embedded NoSQL database for mobile and edge devices, ensuring high data availability [1] Market Position - Couchbase operates in the document database space, alongside MongoDB, with few direct competitors, establishing a solid business model used in various applications [4] - Since its IPO on February 22, 2021, Couchbase's shares have declined over 20%, indicating challenges in the public market [4] Financial Performance - Revenue has increased annually by an average of 19.39% since the IPO, with gross margins consistently between 87% and 89% [5] - Selling, general, and administrative (SG&A) expenses were 91.94% of revenue in 2024, slightly above the average of 91.25% since the IPO, compared to MongoDB's 54.34% [5] - Couchbase has overhired sales personnel, leading to lower attainment rates of 40% to 50% compared to peers achieving 70% to 80% [5] Activist Involvement - Irenic Capital has taken a significant stake in Couchbase, making it one of its five largest positions, focusing on operational restructuring or a potential sale of the company [6][7] - The activist's approach may involve optimizing management and salesforce, improving operating margins while maintaining organic growth [6] Potential Outcomes - A sale to a larger strategic or financial acquirer could allow Couchbase to restructure costs and pursue margin-friendly growth away from public market pressures [7] - Haveli Investments, the largest shareholder with approximately 9.8% ownership, may seek to take Couchbase private, viewing it as undervalued [8] - Comparable transactions in the tech space suggest Couchbase could be valued around 5.2 times revenue, potentially offering a 20% premium to shareholders [8]